Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

WorMe: A user-oriented software for Caenorhabditis elegans length determination

  • Llobet Lladó, Josep
  • Garriga Alonso, Núria
  • Muñoz Juan, Amanda
  • Laromaine, Anna
Caenorhabditis elegans is a widely used animal model for biomedicl research. The lenght of this nematode is commonly used to asses its evelopment and its health. Typically, measurements are performed manually; however, software has been developed to automate this process. Most of these tools are designed for stereomicroscope images, and none work reliably for compound microscopy images. Here we present WorMe, a user-friendly software that measures C.elegans length in compound microscopy images. The program is versatile in handling various image types and can be analyse multiple images collectively. Funthermore, the user can accept of discard the detected objects, separate joined worms, correct erroneous measurements, and manually add new worms. The length results are presented in a spreadsheet file, with earch measurement linked to its image. Graphic data can also be exported., The work has been supported partially with RTI2018-096273B-I00, PID2024-1576370B-I00 (BACTIVE), PDC2023-145826-I00 (BIOCCHIP), funded by MCIN/AEI//10.13039/501100011033/FEDER “Una manera de hacer Europa”; the “Severo Ochoa” Programme for Centres of Excellence, in R&D CEX2019-000917-S (FUNFUTURE), CEX2023-001263-S (MATRANS42); the Generalitat de Catalunya (2021SGR00446 Grant), and European Union’s Horizon Europe research and innovation program under grant agreement No 101057527 (NextGEM). AL participates in CSIC-Conexion Nanomedicina del CSIC, EPNOE network, and Red Nanocare 2.0, Grant RED2022-134560-T funded by MCIN/AEI/10.13039/501100011033, JLL acknowledges ayudas JAE ICU, Consejo Superior de Investigaciones Científicas (CSIC), JAEICU-21-ICMAB01 (2021) in the framework of the Master of Bioinformatics and Biostatistics (UOC, 2021), NGA acknowledges ayudas JAEIntro, Consejo Superior de Investigaciones Científicas (CSIC), JAEINT-24-01745, (2024), AMJ acknowledges the Ph.D. scholarship (FPU18/05190)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S). With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2023-001263-S)., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Advances in Conductive Nanomaterials for Cardiac Arrhythmia and Future Directions in Bioevaluation Strategies

  • Srinivasan, Sumithra Y.
  • Laromaine, Anna
Cardiac arrhythmia (CA), characterized by irregular heart rhythms, affects nearly 90% of individuals with cardiovascular diseases. Commonly triggered by myocardial infarction (MI) or ion channel dysfunctions, CA is traditionally treated using pacemakers, cardioversion, ablation, and anti-arrhythmic drugs. Recently, emerging strategies like cardiac patches and injectable formulations with conductive nanomaterials (CNMs) have shown promise in restoring cardiac rhythm post-MI. This review explores CNMs-such as gold nanoparticles, carbon nanotubes, and conjugated polymers-that mimic the electrical and mechanical properties of native cardiac tissue. While in vitro studies show encouraging results, translating CNMs to clinical settings faces challenges. Few studies have assessed their safety and efficacy in rodent models, and none in larger animals. This gap stems from the complexity and ethical hurdles of large animal research. To address this, the review advocates using small animal models like zebrafish, Drosophila melanogaster, and Caenorhabditis elegans. These models offer insights into pharmacokinetics, pharmacodynamics, genetic effects, and cardiac parameters such as ejection fraction and cardiac output-data often unattainable in vitro. Such platforms can better evaluate CNMs' safety and efficacy than 2D/3D cultures, accelerating progress toward clinical application., This work was supported by the Spanish Ministry of Science and Innovation (MICINN) through the National Research Agency (AEI) and European Regional Development Funds (ERDF/FEDER), project BIOSOFT-REGE ref PID2021-122645OB-I00, BACTIVE ref PID2024-1576370B-I00, BIOCCHIP ref PDC2023-145826-I00, the Program/Generalitat de Catalunya (2021SGR00446 project), the Severo Ochoa Program of the Spanish Ministry of Science and Innovation (MICINN_Grant CEX2018−000,789-S, CEX2023-001263-S), and the projects FIP-BEAT, and the PDC2022-133755-I00/AEI/10.13039/501100011033 European Union NextGeneration EU/PRTR. This research was also supported by the European Union's Horizon 2020 research and innovation program H2020-MSCA-COFUND-2016 (DOC-FAM, Grant Agreement No. 754397), European Union’s Horizon Europe research and innovation program under grant agreement No 101057527 (NextGEM). Authors participate in the Spanish National Research Council (CSIC) interdisciplinary platform for sustainable plastics toward a circular economy (SusPlast), and in CSIC-Conexion Nanomedicina del CSIC, EPNOE network, and Red Nanocare 2.0, Grant RED2022-134560-T funded by MCIN/AEI/10.13039/501100011033. The authors acknowledge the use of Biorender.com., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2023-001263-S)., Peer reviewed